Akshay Gupte | Profiles RNS

Akshay Gupte, PhD, MBBS, MSPH

Assistant Professor

Boston University School of Public Health

Global Health

MD, Maharashtra University of Health Science
PhD, Johns Hopkins University School of Public Health
MSPH, Johns Hopkins University School of Public Health
BA, Maharashtra University of Health Science

Websites

	Google Scholar
	ResearchGate
	LinkedIn

ORCID : 0000-0002-5179-773X

Dr. Gupte is a physician-scientist whose research is focused on the intersection of infectious and chronic lung diseases in low- and middle-income settings. He leads several Indo-US collaborative studies to describe the epidemiology and pathogenesis of lung injury in tuberculosis (TB)/HIV/diabetes, measure its impact on poor clinical outcomes, and identify therapeutic and programmatic interventions to improve post-TB lung health and longevity.

Dr. Gupte serves on several multi-national TB/HIV research consortia, such as the TB Transformative Science Working Group of the AIDS Clinical Trials Group (ACTG), Lung Health Working Group of the International Epidemiology Databases to Evaluate AIDS (IeDEA) network, and is Chairperson of the Clinical and Epidemiology Working Group of the RePORT-India TB Research Consortium.

Dr. Gupte completed his medical training in India, Master’s and Doctoral training from the Johns Hopkins Bloomberg School of Public Health, and has previously served as faculty in the Division of Infectious Diseases, Johns Hopkins School of Medicine. He is a 2017 Fogarty Fellow and recipient of the Arthur M. Dannenberg, Jr., Award for excellence in TB research.

BU Research
NIH RePORTER Research

Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV
09/20/2024 - 08/31/2029 (PI)
NIH/National Institute of Allergy & Infectious Diseases
1R01AI184179-01

Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease
04/05/2023 - 03/31/2026 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R00AI151094-04

TB PuRe: Pulmonary rehabilitation to reduce post-tuberculosis morbidity
09/01/2023 - 08/31/2025 (Subcontract PI)
The Johns Hopkins University NIH NIAID
5R01AI169588-02

TB Aftermath
06/01/2022 - 05/31/2025 (Subcontract PI)
The Johns Hopkins University NIH NIAID
5R01AI143748-03

Title

Yr	Title	Project-Sub Proj
2025	Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV	3R01AI184179-02S1
2025	Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV	3R01AI184179-02S2
2025	Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV	5R01AI184179-02
2025	TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity	3R01AI169588-03S2
2025	TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity	3R01AI169588-03S1
2025	TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity	5R01AI169588-03
2024	Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV	1R01AI184179-01
2024	TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity	5R01AI169588-02
2024	Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease	5R00AI151094-04
2023	TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity	1R01AI169588-01A1

Showing 10 of 13 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website Copy PMIDs To Clipboard

Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Bala Yogendra Shivakumar SV, Salgame P, Bollinger RC, Sarkar S, Gupte AN. Contribution of Key Comorbidities to Unfavorable Treatment Outcomes among Adults with Drug-sensitive Pulmonary Tuberculosis in India: a Prospective Cohort Analysis. Chest. 2025 Sep 10.View Related Profiles.

Gupte, Akshay
Horsburgh, C.
Sinha, Pranay

PMID: 40939932; DOI: 10.1016/j.chest.2025.05.055;

Cox SR, Moe AH, Gupte AN, Kadam A, Valawalkar S, Gupte N, Lele G, Kendall EA, Baillie C, Barthwal MS, Kakrani A, Mave V, Dowdy DW, Golub JE. A point-of-care prediction tool for recurrent tuberculosis. Clin Infect Dis. 2025 Jul 08. PMID: 40626664; DOI: 10.1093/cid/ciaf353;

Tabackman A, Gupte AN, Thangakunam B, Babu SP, Du X, Paradkar M, Shivakumar SVBY, Gaikwad S, Ezhumalai K, Ponnuraja C, Cox S, Gupte N, Tornheim JA, Dauphinais MR, Gupta A, Christopher DJ, Kornfeld H, Mave V, Viswanathan V, Ellner JJ, White LF, Padmapriyadarsini C, Sinha P, Sarkar S. Impact of premorbid nutritional status on TB severity. Int J Tuberc Lung Dis. 2025 May 30; 29(6):265-270.View Related Profiles.

Gupte, Akshay
White, Laura
Sinha, Pranay

PMID: 40495301; DOI: 10.5588/ijtld.24.0592;

Mave V, Cox SR, Gupte AN, Golub JE. Addressing post-tuberculosis sequelae among people living with HIV: an unmet need. J Int AIDS Soc. 2025 Mar; 28(3):e26439. PMID: 40123373; PMCID: PMC11931193; DOI: 10.1002/jia2.26439;

Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh CR, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India. Clin Infect Dis. 2024 Oct 15; 79(4):1034-1038.View Related Profiles.

Gupte, Akshay
Horsburgh, C.
Hochberg, Natasha
Sinha, Pranay

PMID: 38991034; PMCID: PMC11478802; DOI: 10.1093/cid/ciae367;

Gupte AN, Nardell EA. Host-Directed Therapies for Posttuberculosis Lung Disease. NEJM Evid. 2024 Sep; 3(9):EVIDe2400181. PMID: 39189856

Sinha P, Ezhumalai K, Du X, Ponnuraja C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thangakunam B, Paradkar M, Christopher DJ, Mave V, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Padmapriyadarsini C, Gupte A. Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection-a Multicenter Prospective Cohort Analysis. Clin Infect Dis. 2024 Jul 19; 79(1):233-236.View Related Profiles.

Gupte, Akshay
Horsburgh, C.
Sinha, Pranay

PMID: 38652286; PMCID: PMC11259213; DOI: 10.1093/cid/ciae149;

Krishnan S, Gupte N, Paradkar M, Gupte A, Naik M, Raskar S, Suryavanshi N, Pradhan N, Gaikwad S, Karyakarte R, Lokhande R, Luke EH, Thiruvengadam K, Padmapriyadarsini C, Sahasrabudhe T, Barthwal M, Kakrani A, Viswanathan V, Kornfeld H, Gupta A, Golub JE, Mave V. Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohorts. Front Tuberc. 2024; 2. PMID: 40303321; PMCID: PMC12040415; DOI: 10.3389/ftubr.2024.1433975;

Krishnan Sonya , Gupte Nikhil , Paradkar Mandar , Gupte Akshay , Naik Mrunmayi , Raskar Swapnil , Suryavanshi Nishi , Pradhan Neeta , Gaikwad Sanjay , Karyakarte Rajesh , Lokhande Rahul , Hanna Luke Elizabeth , Thiruvengadam Kannan , Padmapriyadarsini Chandrasekaran , Sahasrabudhe Tushar , Barthwal Madhusudan , Kakrani ArjunLal , Viswanathan Vijay , Kornfeld Hardy , Gupta Amita , Golub Jonathan E. , Mave Vidya. Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohorts. Frontiers in Tuberculosis. 2024; 2.

Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hofmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE. Correction: Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts. Trials. 2024 Mar 11; 25(1):178. PMID: 38468342; PMCID: PMC10929208; DOI: 10.1186/s13063-024-07984-3;

Showing 10 of 57 results. Show More

Rocha EF, Vinhaes CL, Araújo-Pereira M, Mota TF, Gupte AN, Kumar NP, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Kulkarni V, Paradkar M, Viswanathan V, Kornfeld H, Gupta A, Andrade BB, Queiroz ATL. The sound of silent RNA in tuberculosis and the lncRNA role on infection. iScience. 2024 Jan 19; 27(1):108662. PMID: 38205253; PMCID: PMC10777062; DOI: 10.1016/j.isci.2023.108662;

Paradkar MS, Pradhan NN, Balaji S, Gaikwad SN, Chavan A, Dharmashale SN, Sahasrabudhe T, Lokhande R, Deshmukh SA, Barthwal M, Atre S, Raskar SS, Sawant TU, Gupte AN, Kakrani A, Golub J, Padmapriyadarsini C, Gupta A, Gupte NA, Mave V. Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes. Ann Am Thorac Soc. 2023 Dec; 20(12):1760-1768. PMID: 38038600; PMCID: PMC10704230; DOI: 10.1513/AnnalsATS.202302-144OC;

Pardeshi G, Mave V, Gaikwad S, Kadam D, Barthwal M, Gupte N, Atre S, Deshmukh S, Golub JE, Gupte A. Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study. Chest. 2024 Feb; 165(2):278-287. PMID: 37673207; PMCID: PMC10851276; DOI: 10.1016/j.chest.2023.08.026;

Queiroz ATL, Vinhaes CL, Fukutani ER, Gupte AN, Kumar NP, Fukutani KF, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Paradhkar M, Viswanathan V, Gupta A, Andrade BB, Kornfeld H. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep. 2023 May 12; 13(1):7769. PMID: 37173394; PMCID: PMC10180618; DOI: 10.1038/s41598-023-34847-9;

Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis. 2023 Apr 17; 76(8):1483-1491.View Related Profiles.

Gupte, Akshay
Horsburgh, C.
Hochberg, Natasha
Sinha, Pranay

PMID: 36424864; PMCID: PMC10319769; DOI: 10.1093/cid/ciac915;

Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar SVBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Golub JE. Characterising cause of death among people treated for drug-susceptible TB in India. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):78-80. PMID: 36853129; PMCID: PMC11609701; DOI: 10.5588/ijtld.22.0454;

Romanowski K, Oravec A, Billingsley M, Shearer K, Gupte A, Huaman MA, Fox GJ, Golub JE, Johnston JC. A scoping review of interventions to mitigate common non-communicable diseases among people with TB. Int J Tuberc Lung Dis. 2022 Nov 01; 26(11):1016-1022. PMID: 36281048; DOI: 10.5588/ijtld.22.0075;

Deshmukh S, Sane M, Gaikwad S, Sahasrabudhe T, Barthwal M, Lokhande R, Raskar S, Kagal A, Dharmshale S, Pradhan N, Gupte A, Alfarisi O, Gupta A, Dooley KE, Gupte N, Golub JE, Mave V. Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in India. Chest. 2023 Apr; 163(4):778-789. PMID: 36174745; PMCID: PMC10258435; DOI: 10.1016/j.chest.2022.09.024;

Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hoffmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts. Trials. 2022 Aug 05; 23(1):635. PMID: 35932062; PMCID: PMC9354295; DOI: 10.1186/s13063-022-06503-6;

Baidya A, Sangle S, Marbaniang I, Kulkarni V, Deshpande P, Nimkar S, Chavan A, Salvi S, Lokhande R, Kadam D, Gupta A, Mave V, Gupte AN. Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India. Open Forum Infect Dis. 2022 Jul; 9(7):ofac233. PMID: 35836747; PMCID: PMC9274441; DOI: 10.1093/ofid/ofac233;

Gupte AN, Kumar P, Araújo-Pereira M, Kulkarni V, Paradkar M, Pradhan N, Menon P, Padmapriyadarsini C, Hanna LE, Yogendra Shivakumar SVB, Rockwood N, Du Bruyn E, Karyakarte R, Gaikwad S, Bollinger R, Golub J, Gupte N, Viswanathan V, Wilkinson RJ, Mave V, Babu S, Kornfeld H, Andrade BB, Gupta A. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. Eur Respir J. 2022 04; 59(4). PMID: 34711538; PMCID: PMC7612881; DOI: 10.1183/13993003.00905-2021;

Shivakumar SVBY, Padmapriyadarsini C, Chavan A, Paradkar M, Shrinivasa BM, Gupte A, Dhanasekaran K, Thomas B, Suryavanshi N, Dolla CK, Selvaraju S, Kinikar A, Gaikwad S, Kohli R, Sivaramakrishnan GN, Pradhan N, Hanna LE, Kulkarni V, DeLuca A, Cox SR, Murali L, Thiruvengadam K, Raskar S, Ramachandran G, Golub JE, Gupte N, Mave V, Swaminathan S, Gupta A, Bollinger RC. Concomitant pulmonary disease is common among patients with extrapulmonary TB. Int J Tuberc Lung Dis. 2022 Apr 01; 26(4):341-347. PMID: 35351239; PMCID: PMC8982647; DOI: 10.5588/ijtld.21.0501;

Shivakoti R, Newman JW, Hanna LE, Queiroz ATL, Borkowski K, Gupte AN, Paradkar M, Satyamurthi P, Kulkarni V, Selva M, Pradhan N, Shivakumar SVBY, Natarajan S, Karunaianantham R, Gupte N, Thiruvengadam K, Fiehn O, Bharadwaj R, Kagal A, Gaikwad S, Sangle S, Golub JE, Andrade BB, Mave V, Gupta A, Padmapriyadarsini C. Host lipidome and tuberculosis treatment failure. Eur Respir J. 2022 01; 59(1). PMID: 34375300; PMCID: PMC9625841; DOI: 10.1183/13993003.04532-2020;

Tornheim JA, Udwadia ZF, Arora PR, Gajjar I, Sharma S, Karane M, Sawant N, Kharat N, Blum AJ, Shivakumar SVBY, Gupte AN, Gupte N, Mullerpattan JB, Pinto LM, Ashavaid TF, Gupta A, Rodrigues C. Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India. Open Forum Infect Dis. 2022 Feb; 9(2):ofab615. PMID: 35097152; PMCID: PMC8794589; DOI: 10.1093/ofid/ofab615;

Kamenar K, Hossen S, Gupte AN, Siddharthan T, Pollard S, Chowdhury M, Rubinstein AL, Irazola VE, Gutierrez L, Miranda JJ, Bernabe-Ortiz A, Alam D, Kirenga B, Jones RC, van Gemert F, Wise RA, Checkley W. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax. 2022 Nov; 77(11):1088-1097. PMID: 34853154

Chidambaram V, Tun NL, Majella MG, Ruelas Castillo J, Ayeh SK, Kumar A, Neupane P, Sivakumar RK, Win EP, Abbey EJ, Wang S, Zimmerman A, Blanck J, Gupte A, Wang JY, Karakousis PC. Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis. Clin Infect Dis. 2021 11 02; 73(9):1580-1588. PMID: 34100919; PMCID: PMC8563313; DOI: 10.1093/cid/ciab527;

Chidambaram V, Gupte A, Wang JY, Golub JE, Karakousis PC. The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes. Clin Infect Dis. 2021 11 02; 73(9):e3409-e3418. PMID: 32971534; PMCID: PMC8563167; DOI: 10.1093/cid/ciaa1446;

Chidambaram V, Ruelas Castillo J, Kumar A, Wei J, Wang S, Majella MG, Gupte A, Wang JY, Karakousis PC. The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis. Sci Rep. 2021 07 27; 11(1):15283. PMID: 34315941; PMCID: PMC8316554; DOI: 10.1038/s41598-021-94590-x;

Chidambaram V, Zhou L, Ruelas Castillo J, Kumar A, Ayeh SK, Gupte A, Wang JY, Karakousis PC. Higher Serum Cholesterol Levels Are Associated With Reduced Systemic Inflammation and Mortality During Tuberculosis Treatment Independent of Body Mass Index. Front Cardiovasc Med. 2021; 8:696517. PMID: 34239907; PMCID: PMC8257940; DOI: 10.3389/fcvm.2021.696517;

Mave V, Gaikwad S, Barthwal M, Chandanwale A, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Kornfeld H, Dooley KE, Chon S, Gupte A, Gupta A, Gupte N, Golub JE. Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India. Open Forum Infect Dis. 2021 Apr; 8(4):ofab097. PMID: 33884278; PMCID: PMC8047862; DOI: 10.1093/ofid/ofab097;

Cox SR, Gupte AN, Thomas B, Gaikwad S, Mave V, Padmapriyadarsini C, Sahasrabudhe TR, Kadam D, Gupte N, Hanna LE, Kagal A, Paradkar M, Thiruvengadam K, Jain D, Atre S, Sekar K, Raskar S, Shivakumar SVBY, Santhappan R, Deshmukh S, Pradhan N, Kulkarni V, Kakrani A, Barthwal MS, Sawant T, DeLuca A, Suryavanshi N, Chander G, Bollinger R, Golub JE, Gupta A. Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men. Int J Tuberc Lung Dis. 2021 03 01; 25(3):182-190. PMID: 33688806

Gupte AN, Selvaraju S, Gaikwad S, Mave V, Kumar P, Babu S, Andrade BB, Checkley W, Bollinger R, Gupta A. Higher interleukin-6 levels and changes in transforming growth factor-ß are associated with lung impairment in pulmonary tuberculosis. ERJ Open Res. 2021 Jan; 7(1). PMID: 33532468; PMCID: PMC7836581; DOI: 10.1183/23120541.00390-2020;

Gupte A, Auld S, Checkley W, Bisson G. Outcomes for Clinical Trials of Host-directed Therapies for Tuberculosis. Springer Publishing. New York. 2020.

Dutta NK, Tornheim JA, Fukutani KF, Paradkar M, Tiburcio RT, Kinikar A, Valvi C, Kulkarni V, Pradhan N, Shivakumar SVBY, Kagal A, Gupte A, Gupte N, Mave V, Gupta A, Andrade BB, Karakousis PC. Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children. Sci Rep. 2020 11 11; 10(1):19527. PMID: 33177551; PMCID: PMC7658223; DOI: 10.1038/s41598-020-75513-8;

Jackson P, Siddharthan T, Argento AC, Sachdeva A, Yarmus L, Gupte A, Katagira W, Kirenga B, Worodria W, Lee HJ. Pilot Project to Assess the Potential Cost-Benefit of a Bronchoscopy Program for the Diagnosis of TB in Uganda. Chest. 2021 05; 159(5):1970-1973. PMID: 33171159; PMCID: PMC8129728; DOI: 10.1016/j.chest.2020.10.072;

Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, S R, Suryavanshi N, B M S, Cox SR, Selvaraju S, Gupte N, Mave V, Gupta A, Bollinger RC. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS One. 2020; 15(7):e0236743. PMID: 32726367; PMCID: PMC7390377; DOI: 10.1371/journal.pone.0236743;

Siddharthan T, Gupte A, Barnes PJ. Chronic Obstructive Pulmonary Disease Endotypes in Low- and Middle-Income Country Settings: Precision Medicine for All. Am J Respir Crit Care Med. 2020 07 15; 202(2):171-172. PMID: 32396738; PMCID: PMC7365372; DOI: 10.1164/rccm.202001-0165ED;

Tornheim JA, Madugundu AK, Paradkar M, Fukutani KF, Queiroz ATL, Gupte N, Gupte AN, Kinikar A, Kulkarni V, Balasubramanian U, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Valvi C, Hanna LE, Andrade BB, Mave V, Pandey A, Gupta A. Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian Children. J Infect Dis. 2020 04 27; 221(10):1647-1658. PMID: 31796955; PMCID: PMC7184902; DOI: 10.1093/infdis/jiz639;

Dooley KE, Savic R, Gupte A, Marzinke MA, Zhang N, Edward VA, Wolf L, Sebe M, Likoti M, Fyvie MJ, Shibambo I, Beattie T, Chaisson RE, Churchyard GJ. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial. Lancet HIV. 2020 06; 7(6):e401-e409. PMID: 32240629; DOI: 10.1016/S2352-3018(20)30032-1;

Ramachandran G, Chandrasekaran P, Gaikwad S, Agibothu Kupparam HK, Thiruvengadam K, Gupte N, Paradkar M, Dhanasekaran K, Sivaramakrishnan GN, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V. Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes. Clin Infect Dis. 2020 03 17; 70(7):1463-1470. PMID: 31075166; PMCID: PMC7931830; DOI: 10.1093/cid/ciz380;

Gupte AN, Paradkar M, Selvaraju S, Thiruvengadam K, Shivakumar SVBY, Sekar K, Marinaik S, Momin A, Gaikwad A, Natrajan P, Prithivi M, Shivaramakrishnan G, Pradhan N, Kohli R, Raskar S, Jain D, Velu R, Karthavarayan B, Lokhande R, Suryavanshi N, Gupte N, Murali L, Salvi S, Checkley W, Golub J, Bollinger R, Mave V, Padmapriyadarasini C, Gupta A. Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. PLoS One. 2019; 14(12):e0226389. PMID: 31805169; PMCID: PMC6894794; DOI: 10.1371/journal.pone.0226389;

Shivakoti R, Dalli J, Kadam D, Gaikwad S, Barthwal M, Colas RA, Mazzacuva F, Lokhande R, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Chon S, Gupte A, Gupta A, Gupte N, Arriaga MB, Fukutani KF, Andrade BB, Golub JE, Mave V. Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes. Prostaglandins Other Lipid Mediat. 2020 04; 147:106398. PMID: 31726221; PMCID: PMC7067657; DOI: 10.1016/j.prostaglandins.2019.106398;

Thomas BE, Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Yogendra Shivakumar SVB, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A. Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored. PLoS One. 2019; 14(11):e0224914. PMID: 31675369; PMCID: PMC6824559; DOI: 10.1371/journal.pone.0224914;

Saranathan R, Sathyamurthi P, Thiruvengadam K, Murugesan S, Shivakumar SVBY, Gomathi NS, Kavitha D, Paradkar M, Puvaneshwari R, Kannan M, Madheswaran A, Pradhan N, Kulkarni V, Gupte AN, Gupte N, Mave V, Bollinger RC, Gupta A, Padmapriyadarsini C, Hanna LE. MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patients. Infect Genet Evol. 2020 01; 77:104093. PMID: 31678649; DOI: 10.1016/j.meegid.2019.104093;

Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A, Nimkar S, Golub J, Gupte N, Gupta A, Marbaniang I, Mave V. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infect Dis. 2019 Oct 29; 19(1):914. PMID: 31664933; PMCID: PMC6820927; DOI: 10.1186/s12879-019-4569-z;

Dolla CK, Padmapriyadarsini C, Thiruvengadam K, Lokhande R, Kinikar A, Paradkar M, Bm S, Murali L, Gupte A, Gaikwad S, Selvaraju S, Padmanaban Y, Pattabiraman S, Pradhan N, Kulkarni V, Shivakumar SVBY, Prithivi M, Kagal A, Karthavarayan BT, Suryavanshi N, Gupte N, Kumaran P, Mave V, Gupta A. Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? Trans R Soc Trop Med Hyg. 2019 10 11; 113(10):632-640. PMID: 31225622; PMCID: PMC6792162; DOI: 10.1093/trstmh/trz049;

Thomas BE, Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Bala Yogendra Shivakumar SV, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A. Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored. PLoS One. 2019; 14(7):e0220507. PMID: 31365583; PMCID: PMC6668833; DOI: 10.1371/journal.pone.0220507;

Mave V, Chandrasekaran P, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, Thiruvengadam K, Kinikar A, Murali L, Gaikwad S, Hanna LE, Kulkarni V, Pattabiraman S, Suryavanshi N, Thomas B, Kohli R, Sivaramakrishnan GN, Pradhan N, Bhanu B, Kagal A, Golub J, Gandhi N, Gupte A, Gupte N, Swaminathan S, Gupta A. Infection free "resisters" among household contacts of adult pulmonary tuberculosis. PLoS One. 2019; 14(7):e0218034. PMID: 31318864; PMCID: PMC6638997; DOI: 10.1371/journal.pone.0218034;

Gupte AN, Paradkar M, Selvaraju S, Thiruvengadam K, Shivakumar SVBY, Sekar K, Marinaik S, Momin A, Gaikwad A, Natrajan P, Prithivi M, Shivaramakrishnan G, Pradhan N, Kohli R, Raskar S, Jain D, Velu R, Karthavarayan B, Lokhande R, Suryavanshi N, Gupte N, Murali L, Salvi S, Checkley W, Golub J, Bollinger R, Mave V, Padmapriyadarasini C, Gupta A. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. PLoS One. 2019; 14(5):e0217289. PMID: 31120971; PMCID: PMC6532904; DOI: 10.1371/journal.pone.0217289;

Gupte AN, Selvaraju S, Paradkar M, Danasekaran K, Shivakumar SVBY, Thiruvengadam K, Dolla C, Shivaramakrishnan G, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Subramanian B, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub JE, Bollinger R, Chandrasekaran P, Mave V, Gupta A. Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2019 04 01; 23(4):450-457. PMID: 31064624

Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One. 2018; 13(8):e0199360. PMID: 30067752; PMCID: PMC6070176; DOI: 10.1371/journal.pone.0199360;

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE. Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India. Int J Tuberc Lung Dis. 2018 07 01; 22(7):800-806. PMID: 30041729; PMCID: PMC6198328; DOI: 10.5588/ijtld.18.0026;

Gupte AN, Wong ML, Msandiwa R, Barnes GL, Golub J, Chaisson RE, Hoffmann CJ, Martinson NA. Factors associated with pulmonary impairment in HIV-infected South African adults. PLoS One. 2017; 12(9):e0184530. PMID: 28902919; PMCID: PMC5597201; DOI: 10.1371/journal.pone.0184530;

Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, Meshram S, Bharadwaj R, Khadse S, Ramachandran G, Hanna LE, Pradhan N, Gomathy NS, DeLuca A, Gupta A, Swaminathan S. Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study. BMJ Open. 2016 Feb 25; 6(2):e010542. PMID: 26916698; PMCID: PMC4769396; DOI: 10.1136/bmjopen-2015-010542;

Gupta A, Montepiedra G, Gupte A, Zeldow B, Jubulis J, Detrick B, Violari A, Madhi S, Bobat R, Cotton M, Mitchell C, Spector S. Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants. PLoS One. 2016; 11(2):e0148649. PMID: 26872154; PMCID: PMC4752266; DOI: 10.1371/journal.pone.0148649;

Joshi M, Patel H, Gupte S, Gupte A. Nutrient improvement for simultaneous production of exopolysaccharide and mycelial biomass by submerged cultivation of Schizophyllum commune AGMJ-1 using statistical optimization. 3 Biotech. 2013 Aug; 3(4):307-318. PMID: 28324588

Gahlout M, Gupte S, Gupte A. Optimization of culture condition for enhanced decolorization and degradation of azo dye reactive violet 1 with concomitant production of ligninolytic enzymes by Ganoderma cupreum AG-1. 3 Biotech. 2013 Apr; 3(2):143-152. PMID: 28324569

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 57 publications over 11 distinct years, with a maximum of 10 publications in 2019